Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: FEBS J. 2015 Dec 17;283(3):459–471. doi: 10.1111/febs.13593

Figure 1.

Figure 1

Distribution of samples by set and proteomics technique. Sample set 1 includes samples used for Myriad RBM immunoassay on the left and 2D-DIGE on the right. In sample set 2, Western blot samples are a subset of those used for the MILLIPLEX® MAP immunoassay.